New Zealand markets closed

iRobot Corporation (IRBT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.64+0.05 (+0.58%)
As of 03:11PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 240.22M
Enterprise value 289.42M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.27
Price/book (mrq)1.22
Enterprise value/revenue 0.32
Enterprise value/EBITDA -1.25

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 3-80.40%
S&P500 52-week change 329.57%
52-week high 351.49
52-week low 37.82
50-day moving average 312.58
200-day moving average 331.90

Share statistics

Avg vol (3-month) 32.99M
Avg vol (10-day) 32.47M
Shares outstanding 527.96M
Implied shares outstanding 627.96M
Float 826.58M
% held by insiders 12.14%
% held by institutions 179.68%
Shares short (15 Mar 2024) 49.44M
Short ratio (15 Mar 2024) 43.84
Short % of float (15 Mar 2024) 447.51%
Short % of shares outstanding (15 Mar 2024) 433.74%
Shares short (prior month 15 Feb 2024) 48.93M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Jan 2022
Most-recent quarter (mrq)30 Dec 2023

Profitability

Profit margin 1.94%
Operating margin (ttm)-10.14%

Management effectiveness

Return on assets (ttm)0.76%
Return on equity (ttm)4.00%

Income statement

Revenue (ttm)1.56B
Revenue per share (ttm)56.52
Quarterly revenue growth (yoy)-14.10%
Gross profit (ttm)N/A
EBITDA 45.47M
Net income avi to common (ttm)30.39M
Diluted EPS (ttm)-11.01
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)185.12M
Total cash per share (mrq)6.85
Total debt (mrq)234.33M
Total debt/equity (mrq)119.26%
Current ratio (mrq)2.00
Book value per share (mrq)26.54

Cash flow statement

Operating cash flow (ttm)-31.97M
Levered free cash flow (ttm)-56.9M